Thomas White International Ltd. continued to hold its position in shares of Danaher Corporation (NYSE:DHR) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,830 shares of the conglomerate’s stock at the end of the first quarter. Thomas White International Ltd.’s holdings in Danaher Corporation were worth $413,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of DHR. Peddock Capital Advisors LLC increased its stake in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares in the last quarter. Motco increased its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares in the last quarter. Baystate Wealth Management LLC increased its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares in the last quarter. Integrated Investment Consultants LLC increased its stake in Danaher Corporation by 22.1% in the first quarter. Integrated Investment Consultants LLC now owns 2,168 shares of the conglomerate’s stock worth $185,000 after buying an additional 393 shares in the last quarter. Finally, Cedar Wealth Management LLC increased its stake in Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock worth $196,000 after buying an additional 115 shares in the last quarter. Institutional investors and hedge funds own 76.30% of the company’s stock.

Shares of Danaher Corporation (NYSE:DHR) opened at 85.47 on Tuesday. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.01. The firm has a market cap of $59.33 billion, a price-to-earnings ratio of 26.05 and a beta of 1.05. The stock has a 50 day moving average of $84.47 and a 200 day moving average of $83.63.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, April 20th. The conglomerate reported $0.85 EPS for the quarter, beating the Zacks’ consensus estimate of $0.84 by $0.01. Danaher Corporation had a net margin of 12.30% and a return on equity of 11.82%. The company had revenue of $4.21 billion for the quarter, compared to analyst estimates of $4.17 billion. During the same quarter last year, the firm posted $1.08 earnings per share. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. Equities analysts predict that Danaher Corporation will post $3.93 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Wednesday, June 28th. Danaher Corporation’s dividend payout ratio is 17.02%.

ILLEGAL ACTIVITY NOTICE: “Thomas White International Ltd. Continues to Hold Stake in Danaher Corporation (DHR)” was first published by Daily Political and is owned by of Daily Political. If you are reading this piece on another site, it was stolen and reposted in violation of international copyright legislation. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/07/18/thomas-white-international-ltd-continues-to-hold-stake-in-danaher-corporation-dhr.html.

A number of analysts recently commented on DHR shares. BTIG Research reissued a “buy” rating and set a $92.00 price objective on shares of Danaher Corporation in a report on Sunday, April 23rd. Zacks Investment Research downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Wednesday, July 12th. Royal Bank Of Canada reissued a “sector perform” rating and set a $88.00 price objective (down previously from $89.00) on shares of Danaher Corporation in a report on Friday, April 21st. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Finally, Wells Fargo & Company began coverage on shares of Danaher Corporation in a report on Thursday, July 13th. They issued a “market perform” rating and a $90.00 price target on the stock. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $92.11.

In related news, EVP William K. Daniel sold 17,444 shares of the business’s stock in a transaction on Tuesday, April 25th. The shares were sold at an average price of $83.07, for a total transaction of $1,449,073.08. Following the transaction, the executive vice president now owns 132,995 shares of the company’s stock, valued at $11,047,894.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Angela S. Lalor sold 10,815 shares of the business’s stock in a transaction on Tuesday, May 23rd. The stock was sold at an average price of $84.16, for a total transaction of $910,190.40. Following the transaction, the senior vice president now directly owns 39,020 shares in the company, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. In the last three months, insiders sold 82,265 shares of company stock worth $6,815,839. Insiders own 12.20% of the company’s stock.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.